Could Novo-Catalent deal face antitrust hurdles? February 7, 2024 AutoBot News 0 Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.